PMV Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Pmv Pharmaceuticals

12/05/2022 14:31

* PMV Pharmaceuticals Inc  PMVP.OQ  reported a quarterly
adjusted
loss of 41 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 40 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * PMV Pharmaceuticals Inc's reported EPS for the quarter was
a
loss of 41 cents​.
    * The mean earnings estimate of analysts had fallen by
about 11%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * PMV Pharmaceuticals Inc shares had fallen by 41.1% this
quarter and lost 46.9% so far this year.
    * The company reported a quarterly loss of $18.43 million.
    * Wall Street's median 12-month price target for PMV
Pharmaceuticals Inc is $46.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 01:30 p.m.  ​All
figures in US dollars unless otherwise stated